ELUT
Elutia Inc.
$0.96
+0.05 (+5.25%)
At close · Jul 15
Market Cap
$42.00M
Shares
44,208,236
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$12.29M
-15%
FY2025
Net Income
$53.38M
+198.9%
FY2025
Gross Margin
53.66%
+7.2pp
FY2025
Operating Margin
-218.91%
-6.6pp
FY2025
Diluted EPS
$0.87
+146.8%
FY2025
Operating Cash Flow
-$44.81M
-97.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| $12.46M | $12.29M | $14.47M | $24.75M | $23.85M | $47.39M | $42.68M | $42.9M | |
| $5.44M | $5.7M | $7.75M | $13.69M | $12.21M | $28.37M | $22.12M | $23.13M | |
| $7.02M | $6.6M | $6.72M | $11.05M | $11.64M | $19.02M | $20.56M | $19.77M | |
| — | 53.66% | 46.42% | 44.67% | 48.8% | 40.14% | 48.17% | 46.08% | |
| $5.27M | $4.16M | $3M | $4.4M | $7.73M | $9.27M | $5.95M | $2.4M | |
| $6.25M | $5.77M | $4.99M | $13.09M | $17.85M | $18.83M | $17.57M | $16.16M | |
| $15.45M | $15.08M | $18.07M | $14.1M | $16.05M | $13.69M | $10.64M | $9.62M | |
| — | $1.1M | $1.1M | $3.4M | $3.4M | $3.4M | $3.4M | $3.4M | |
| — | $2.79M | $3.45M | $3.75M | $3.73M | $3.73M | $3.86M | $3.86M | |
| $33.5M | $33.51M | $37.43M | $41.58M | $46.83M | $42.05M | $34.16M | $28.18M | |
| -$26.48M | -$26.91M | -$30.71M | -$30.53M | -$35.19M | -$23.03M | -$13.6M | -$8.41M | |
| — | -218.91% | -212.29% | -123.36% | -147.55% | -48.6% | -31.86% | -19.6% | |
| — | -$24.13M | -$27.26M | -$26.78M | -$31.46M | -$19.3M | -$9.74M | -$4.55M | |
| $3.94M | — | $4.78M | $5.8M | $5.12M | $5.32M | $5.63M | $5.38M | |
| — | -$2.76M | $1.19M | -$759K | $4.16M | $3.58M | -$2.57M | $1.88M | |
| -$21.8M | -$15.86M | -$45.34M | -$41.22M | -$36.15M | -$24.78M | -$21.8M | -$11.91M | |
| $75K | $13K | $7000 | $28K | $34K | $55K | $26K | $30K | |
| $49.84M | $53.38M | -$53.95M | -$37.66M | -$32.9M | -$24.83M | -$21.83M | -$11.94M | |
| — | 434.23% | -372.91% | -152.18% | -137.94% | -52.4% | -51.13% | -27.83% | |
| — | $53.38K | -$53.95K | -$37.66M | -$32.9M | -$24.83M | -$25.34M | -$11.94M | |
| USD/shares | — | $1.29 | -$1.86 | -$2.07 | -$2.38 | -$2.38 | -$8.88 | — |
| USD/shares | — | $0.87 | -$1.86 | -$2.07 | -$2.38 | -$2.38 | -$8.88 | — |
| shares | — | 41.42M | 29.07M | 18.16M | 13.83M | 10.44M | 2.85M | 645.99K |
| shares | — | 45.94M | 29.07M | 18.16M | 13.83M | 10.44M | 2.85M | 645.99K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Medical Devices median 2.27×
EV/EBIT
—
Medical Devices median 21.71×
P/E (TTM)
1.04×
Medical Devices median 28.52×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Women S Health | $9,138,000 | $11,553,000 | $10,304,000 |
| Cardiovascular | $3,155,000 | $2,914,000 | $5,040,000 |
| Device Protection | — | — | $9,401,000 |
By Product & Service (USD)
| Component | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Women S Health | $10,304,000 | $7,474,000 | — |
| Device Protection | $9,401,000 | $9,093,000 | — |
| Cardiovascular | $5,040,000 | $7,282,000 | — |
| Cardiovascular | — | — | $7,508,000 |
| Device Protection | — | — | $7,902,000 |
| Orthobiologics | — | — | $26,934,000 |
| Women's Health | — | — | $5,046,000 |